The Hydropothecary Corporation
Latest The Hydropothecary Corporation News and Updates
CannabisShould Investors Buy HEXO (HEXO) Stock on the Dip or Wait?
HEXO stock has returned 88 percent YTD. Recently, the stock has lost some of its value. Will HEXO stock fall more or go up? Company & Industry OverviewsTop Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors. CannabisAurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter. CannabisAurora Cannabis’s Price Target Cut by 30%
Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1. CannabisCannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds. CannabisHEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars. CannabisWhat Do Analysts Recommend for Canopy Growth?
On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release. Real EstateComparing the Valuation Multiples of Cannabis Stocks
In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x. CannabisCronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group. CannabisWhy Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why. CannabisSouth Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year. CannabisWhy Medical Cannabis Lacks Scientific History
Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science. CannabisMedical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil. CannabisMarijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization. CannabisCannabis 3.0: Is It on the Horizon?
On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next? CannabisMarijuana: Why Is Washington Changing Its Laws?
In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws. CannabisMarijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana. CannabisWhy Does Jim Cramer Prefer CGC versus CRON?
Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters. CannabisCannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market. Company & Industry OverviewsWhy Cannabis Stocks Are on the Rise
The reason cannabis stocks are rising could be because October 17 is approaching. CannabisWas CGC a Big Mistake for Constellation Brands?
Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29. CannabisWhy Aurora Cannabis Wants to Grow Cannabis Outdoors
Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites. CannabisCannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET. CannabisWhat’s Canopy Growth Strategy for Growth?
Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year. MaterialsIIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today. CannabisMarijuana Legalization: What’s Happening in Utah?
Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020. CannabisMarijuana: Why Did Mexico Delay Legalization?
Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.Cannabis New Gallup Poll on Marijuana Legalization Support
A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […] CannabisCannabis Stocks: What Happens in a Recession?
As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.Cannabis Know the Pros and Cons of Cannabis Edibles
Deloitte says that the Canadian edibles market could reach 2.7 billion Canadian dollars per year. Cannabis 2.0 could help cannabis stocks recover. CannabisAre Cannabis Edibles Coming to Maryland Soon?
Recreational cannabis isn’t legal in Maryland, but the state has been trying to launch edibles as part of its medical marijuana program. CannabisGet Real: Breaking Down and Bouncing Back
In this morning’s edition of Get Real, we saw that WeWork’s layoffs are taking a toll. Meanwhile, the cannabis industry could be bouncing back. CannabisMarijuana Legalization Catches Federal Reserve Bank’s Attention
The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis. CannabisWill Hexo Continue to Struggle in 2020?
For the second quarter of fiscal 2020, analysts expect Hexo’s revenue to grow 25.5% YoY (year-over-year) to 16.8 million Canadian dollars. CannabisAnalyzing the Top 3 CBD Companies to Buy in July
Charlotte’s Web Holdings (NYSEARCA:CWEB) is one of the main players in the CBD business. The company plans to keep expanding in 2020. CannabisMarijuana Legalization Hopes Rise in Nebraska for 2020
Marijuana legalization hopes never really ended in Nebraska. Signature gathering paused in the state amid the pandemic and the lockdown. CannabisMarijuana Legalization Still Has a Chance in Idaho
Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign. CannabisCanopy Growth Lays Off More Employees, Latest Strategic Review Round
Canopy Growth laid off an unspecified number of employees on Thursday. So far, the company has laid off 800 employees this year. Earnings ReportWill Hexo Stock Keep Rising after Its Q3 Earnings?
Hexo (TSE:HEXO) stock has been rising high before its third-quarter earnings results. The company will likely report its results before the market bell on Thursday. CannabisBermuda Seeks Public Feedback on Legal Cannabis Market
Bermuda wants to expand its legal cannabis market. The government wants public feedback before the upcoming Bermuda Parliament sessions. CannabisHEXO Received License Amendment, Stock Rose Monday
On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario. CannabisConstellation Brands Hikes Its Stake in Canopy Growth
Constellation Brands (NYSE:STZ) expressed its confidence in Canopy Growth (NYSE:CGC)(TSE:WEED) by increasing its stake in the company. CannabisIs Aphria a Viable Investment in the Cannabis Space?
Cannabis stocks have underperformed the broader markets. Despite the underperformance, Aphria’s recent financial performance was impressive. CannabisWill Hexo Rebound with Its Molson Coors CBD Deal?
Hexo (TSE:HEXO) has been struggling for a while now and things aren’t looking good. The stock has lost close to 70.2% year-to-date. CannabisWhy Did Canopy Growth Stock Rise on Monday?
Canopy Growth (NYSE:CGC)(TSE:WEED) stock rose to a high of 22.66 Canadian dollars before closing at 21.46 Canadian dollars on Monday. CannabisAurora Cannabis Stock Falls on Reverse Stock Split Decision
Aurora Cannabis announced its plan to raise capital and strengthen its liquidity position through a reverse stock split amid the financial crisis. CannabisIdaho Suspends Marijuana Legalization amid Coronavirus
Medical marijuana legalization won’t happen in Idaho in 2020 due to the coronavirus pandemic. The ICC couldn’t gather the required signatures. CannabisMarijuana Legalization Won’t Happen in New York in 2020
New York lawmakers decided to delay marijuana legalization due to the COVID-19 pandemic. As a result, New York won’t see marijuana legalization in 2020. CannabisAnalysts Cut Target Prices after HEXO’s Q2 Earnings
Hexo (TSE:HEXO) reported its second-quarter earnings on March 30. For the quarter, the company missed analysts’ revenue expectations marginally. CannabisMedMen Withdrew Its Guidance amid COVID-19 Pandemic
MedMen stock fell by 12.0% on March 30 after the company released some corporate updates. MedMen has been struggling with a cash crunch.